An anonymous director reports

SIRONA BIOCHEM INITIATES GLYCOPROTEMIMTM TRADEMARK FOR ANTI-AGING MOLECULE TFC-1326

Sirona Biochem Corp. is making a strategic move in the world of advanced skin care solutions. The company trademarking is its groundbreaking anti-aging and anti-wrinkle molecule, TFC-1326, as GlycoProteMim.

This pivotal decision marks a significant milestone in Sirona Biochem's mission to bring forth a new era of skin care innovation. The trademarking of GlycoProteMim, filed with the Instituto Nacional da Propriedade Industrial (INPI) and the United States Trademark and Patent Office, demonstrates the company's unwavering commitment to revolutionizing the cosmetics industry with cutting-edge science and unparalleled anti-aging solutions.

With over two decades of research and development, Sirona Biochem has developed GlycoProteMim (TFC-1326) into a powerful solution to reverse skin aging. The molecule has proven to be a game changer in the fight against aging, offering a diverse range of permanent benefits.

Sirona Biochem has begun the trademarking process through its subsidiary TFChem and is actively engaging industry experts to chart the most effective course for commercializing GlycoProteMim. This strategic move underscores the company's dedication to delivering a unique and transformative anti-aging solution to the $12.5-billion global anti-aging market.

The choice to trademark GlycoProteMim goes beyond a mere formality; it stands as a testament to Sirona Biochem's commitment to revolutionizing beauty through scientific innovation. Through rigorous research and clinical trials, the company firmly believes that this name will soon be associated with timeless, radiant skin.

Sirona Biochem is certain that GlycoProteMim will surpass the current gold standard, retinol, in its ability to reverse skin aging. Unlike other products on the market, GlycoProteMim provides powerful results with exceptional tolerability.

About Sirona Biochem Corp.

Sirona Biochem is a leading biotech company with a proprietary formulation platform technology. Specializing in cosmetic ingredient and drug discovery, Sirona Biochem has developed a process to stabilize carbohydrate molecules, to improve efficacy and safety for different applications.

Sirona's compounds are licensed to leading cosmetics and pharma companies around the world in return for licensing fees, milestone payments and continuing royalty payments. Sirona's R&D unit laboratory, TFChem, is located in France and is the recipient of multiple French national scientific awards and European Union and French government grants.

We seek Safe Harbor.